Opko Health (OPK) Liabilities and Shareholders Equity (2010 - 2026)

Opko Health has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $1.9 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 12.76% year-over-year to $1.9 billion; the trailing twelve-month figure through Mar 2026 stood at $7.8 billion (down 9.43% YoY), and the FY2025 full-year result was $1.9 billion, down 12.19% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $1.9 billion, down from $1.9 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $2.4 billion in Q2 2022, with the low at $1.9 billion in Q1 2026.
• Historically, Liabilities and Shareholders Equity has averaged $2.1 billion across 5 years, with a median of $2.1 billion in 2025.
• Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity gained 9.7% — and 2026, when it slipped 12.76%.
• Opko Health's Liabilities and Shareholders Equity stood at $2.2 billion in 2022, then slipped by 7.18% to $2.0 billion in 2023, then gained by 9.37% to $2.2 billion in 2024, then fell by 12.19% to $1.9 billion in 2025, then fell by 3.89% to $1.9 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $1.9 billion (Q1 2026), $1.9 billion (Q4 2025), and $2.0 billion (Q3 2025), per Business Quant data.